In Vivo HOXB7 Gene Silencing and Cotreatment with Tamoxifen for Luminal A Breast Cancer Therapy DOI Creative Commons
Ana Beatriz Caribé dos Santos Valle, Fábio Fernando Alves da Silva,

Maria Ângela Pepe Carneiro

и другие.

Pharmaceuticals, Год журнала: 2024, Номер 17(10), С. 1325 - 1325

Опубликована: Окт. 4, 2024

Acquired resistance and adverse effects are some of the challenges faced by thousands Luminal A breast cancer patients under tamoxifen (TMX) treatment. Some authors associate overexpression HOXB7 with TMX in this molecular subtype, knockdown gene could be an effective strategy to regain sensitivity. Therefore, we used calcium phosphate hybrid nanoparticles (HNP) for delivery short interfering RNA molecule (siRNA) complementary evaluated interference (RNAi) associated treatment vivo.

Язык: Английский

MRS and Optical Imaging Studies of Therapeutic Response to Combination Therapy Targeting BRAF/MEK in Murine Melanomas DOI Creative Commons
Pradeep Kumar Gupta, Lin Z. Li,

Dinesh Kumar Singh

и другие.

Academic Radiology, Год журнала: 2025, Номер unknown

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives DOI Creative Commons

Xuan-Yu Gu,

Jiali Yang, Rui Lai

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Март 26, 2025

Lactate has emerged as a key regulator in the tumor microenvironment (TME), influencing both progression and immune dynamics. As byproduct of aerobic glycolysis, lactate satisfies metabolic needs proliferating cells while reshaping TME to facilitate evasion. Elevated levels inhibit effector such CD8 + T natural killer cells, supporting immunosuppressive regulatory myeloid-derived suppressor thus fostering an environment. promotes epigenetic reprogramming, stabilizes hypoxia-inducible factor-1α, activates nuclear factor kappa B, leading further immunological dysfunction. In this review, we examined role suppression, treatment resistance. We also discuss promising therapeutic strategies targeting metabolism, including dehydrogenase inhibitors, monocarboxylate transporter neutralization methods, all which can restore function enhance immunotherapy outcomes. By highlighting recent advances, review provides theoretical foundation for integrating lactate-targeted therapies into clinical practice. highlight potential synergy between these current immunotherapeutic strategies, providing new avenues addressing TME-related challenges improving outcomes patients with cancer.

Язык: Английский

Процитировано

0

Tumor Microenvironment Lactate: Is It a Cancer Progression Marker, Immunosuppressant, and Therapeutic Target? DOI Creative Commons
Eugene Y. Kim,

Joyce Abides,

Chandler R. Keller

и другие.

Molecules, Год журнала: 2025, Номер 30(8), С. 1763 - 1763

Опубликована: Апрель 15, 2025

The “Warburg effect” is a term coined century ago for the preferential use of glycolysis over aerobic respiration in tumor cells energy production, even under conditions. Although this less efficient mechanism generating from glucose, glycolysis, addition to canonical anaerobic an effective means lactate production. abundant waste product, lactate, yielded by dual tumor, has been discovered be major biomolecule that drives cancer progression. Lactate metabolic source that, via cell membrane transporters, shuttles and out as well cell-associated stromal immune within microenvironment (TME). Additionally, serves pH tuner, signaling ligand transducer, epigenetic gene transcription regulator, TME modifier, suppressor, chemoresistance modulator, prognostic marker. With such broad functionalities, production–consumption–reproduction fuels growth dissemination. Here, we elaborate on sources contribute pool TME, functions influence function local tissue immunity, anticancer therapeutic approaches adopting manipulations their efficacies. By scrutinizing these properties others have addressed field, it expected better weighing development, progression, prognosis, efficacy can achieved.

Язык: Английский

Процитировано

0

Navigating the tumor landscape: VEGF, MicroRNAs, and the future of cancer treatment DOI
K P Ameya,

Parveen Usman,

Durairaj Sekar

и другие.

Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, Год журнала: 2025, Номер 1868(2), С. 195091 - 195091

Опубликована: Май 3, 2025

Язык: Английский

Процитировано

0

Protonophore activity of short‐chain fatty acids induces their intracellular accumulation and acidification DOI Creative Commons
M. Jiang, Frans Bianchi, Geert van den Bogaart

и другие.

FEBS Letters, Год журнала: 2025, Номер unknown

Опубликована: Май 5, 2025

Short‐chain fatty acids (SCFAs), produced by dietary fiber fermentation in the colon, play essential roles cellular metabolism, with butyrate notably modulating immune responses and epigenetic regulation. Their production contributes to an acidic colonic environment where protonated SCFAs permeate membranes, leading intracellular acidification SCFA accumulation. Using our method measure pH, we investigated how extracellular pH influences butyrate‐induced immunomodulatory effects human macrophages. Our data show that accumulates acidifies cells at due permeability of its form. While inflammatory cytokine was mildly influenced histone acetylation exhibited a dependence, underscoring importance considering when assessing SCFA's functions.

Язык: Английский

Процитировано

0

Physiological Oxygen Levels in the Microenvironment Program Ex Vivo-Generated Conventional Dendritic Cells Toward a Tolerogenic Phenotype DOI Creative Commons
Antonia Peter, Marijn A. Vermeulen, Mats Van Delen

и другие.

Cells, Год журнала: 2025, Номер 14(10), С. 736 - 736

Опубликована: Май 18, 2025

Dendritic cells (DCs) are critical regulators of immune homeostasis, balancing tolerance and immunity through antigen presentation T cell modulation. While the influence hypoxia (<2% O2) on DC function in pathological settings is well-documented, impact physiological O2 levels remains underexplored. This study investigates role physioxia (4% programming mature DCs toward a tolerogenic phenotype compared to atmospheric conditions (21% typically present vitro assays. cultures generated under 4% exhibited reduced monocyte-to-DC transformation rate, increased lactate production, semi-mature surface marker profile, expression tolerance-associated ILT4. priming was altered only when were co-cultured physioxia, suggesting an O2-dependent threshold for immunostimulatory capacity. These findings highlight complexity mechanisms DC-T interactions, revealing delicate balance between immunogenicity. Our results underscore need physiologically relevant research better reflect vivo behavior inform immunotherapy design. Overall, this advances understanding how microenvironmental cues shape biology, with implications tolerance, autoimmunity, cancer immunotherapy.

Язык: Английский

Процитировано

0

Anticancer Effects of Doxorubicin-Conjugated Magnetite MXene/Callicarpa Extract on MCF-7 Breast Cancer Cell Line DOI

Mehdi Jabbarzadeh,

Pardis Zaboli,

Fereshteh Chekin

и другие.

Talanta, Год журнала: 2025, Номер 295, С. 128380 - 128380

Опубликована: Май 24, 2025

Язык: Английский

Процитировано

0

Extracellular vesicle proteomics in brain solid tumors: future strategy for personalized medicine DOI
Sonia Spinelli,

Andrea Garbarino,

Marco Pavanello

и другие.

Expert Review of Proteomics, Год журнала: 2025, Номер unknown

Опубликована: Май 30, 2025

Brain solid tumors are a leading cause of cancer-related mortality at all ages. The updated 2021WHO Central Nervous System tumor classification is based on genomic diagnostics. Nonetheless, extracellular vesicles (EVs) proteomics platform for protein biomarker discovery in brain patient management. Tumor metabolic reprogramming, also through epigenetic mechanisms, central to cancer. EVs transfer proteins and nucleic acids that relay the redox state parent cells. This review addresses translation focusing recent (from 2022-2024 PubMed) proteomic studies patients, selected their focus aspects. most treatable adult isocitrate dehydrogenase-mutated glioma. Minimally invasive collection from cerebrospinal fluid or prospectively blood allows analysis CSF express key CNS biomarkers therapy targets undetectable whole adaptations. Metabolic dependencies can represent potential targets. clinical implications EV promising diagnostic prognostic purposes tumors,

Язык: Английский

Процитировано

0

Harnessing Metal Nanoparticles: Revolutionizing Cancer Therapy Through Targeted Drug Delivery and Tumor Microenvironment Modulation DOI
Kiran Dudhat

NANO, Год журнала: 2024, Номер 19(10)

Опубликована: Май 4, 2024

Cancer remains a significant global health burden, claiming countless lives annually and incurring substantial direct indirect economic costs. Despite advancements in therapeutic modalities, conventional cancer treatments, including chemotherapy, radiotherapy surgery, are often hampered by limitations such as insufficient efficacy, dose-dependent side effects, high costs patient tolerability. This has spurred extensive research into novel approaches for this life-threatening disease. Metal nanoparticles (MNPs) have emerged promising tools therapy due to their unique physicochemical properties spanning the past two decades. Owing size similarity biological molecules, MNPs possess inherent ability penetrate cellular barriers, making them ideal carriers targeted drug delivery. These multifunctional nanoplatforms offer distinct advantages over therapeutics enabling delivery of anticancer agents specific tumor sites, thereby enhancing efficacy minimizing systemic effects. Photodynamic sonodynamic represent particularly strategies that leverage treatment. review delves potential applications modulating microenvironment, paving way exploration vast rapidly evolving field nanomedicine.

Язык: Английский

Процитировано

2

Targeting Macrophages as a Novel Therapy to Treat Triple-Negative Breast Cancer: A Literature Review DOI Creative Commons
Callum Todrick, J. Ma, M. Singh

и другие.

Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal, Год журнала: 2024, Номер 8(4), С. 1 - 9

Опубликована: Апрель 19, 2024

Triple-negative breast cancer (TNBC) is a highly aggressive form of which lacks the traditional cellular targets other types cancer. As such, it increasingly important to find alternative treat this deadly disease. Recently, tumour-associated macrophages (TAMs) have become an exciting area focus for research and may provide source treatment options TNBC. Macrophages are part innate immune response also play crucial role in tumour progression, inflammation, metastasis. TAMs fall along spectrum generally presented as either M1 type or M2 type. considered anti-tumorigenic whereas pro-tumorigenic, promoting growth inhibiting T-cell response. A search University Alberta's online library database was carried out with specific emphasis on clinical research. Search efforts focused effects progression Further searches were performed determine efficacy targeting Increasing relative ratio depletion lead better prognosis be repolarized phenotype using metformin, inhibition SerpinE2, YAP/STAT3, MED1/PPARy. Macrophage recruitment microenvironment inhibited by chemokines such CCL2. Current methods could not efficiently deplete at high abundance. The abundance their phagocytic properties instead exploited increase cell phagocytosis CD47-SIRPɑ axis. Exciting opportunities been revealed regarding macrophage recruitment, repolarization type, through exploitation macrophages. However, conflicting results can found all these emerging strategies. Worsening matters lack knowledge functions confusing landscape current naming conventions. further required target treatment.

Язык: Английский

Процитировано

1